The Ministry of Food and Drug Safety announced on the 31st that it has approved the rare drug "Voxzogo" for treating ...

Korean scientists discover a groundbreaking method to transform ordinary fibroblasts into mature cardiomyocytes SEOUL, South Korea, Dec. 26, 2024 ...

CEO Emil D. Kakkis sold 11,727 shares of the stock in a transaction dated Monday, December 30th. The stock was sold at an ...

Inc. (NASDAQ:ETNB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the firm, Marketbeat.com reports. Two equities research ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Erdafitinib is under clinical development by Johnson & Johnson and currently in Phase I for Lung Adenocarcinoma.

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Endothelial cells are also likely to participate in activation, both by production of cellular fibronectin and via conversion of transforming growth factor (TGF)-beta from the latent to active ...

Discover the latest on Akero Therapeutics, Inc., a biotech firm focusing on metabolic balance therapies, with a market cap of ...

A research team has unveiled an innovative technique to convert fibroblasts-common connective tissue cells-into mature and functional induced cardiomyocytes (iCMs). Their method relies on ...

Here are the top medical news for the day:Review Highlights Transformative Journey from Stethoscope to Wearable Sensors for ...

requiring substantial growth and overcoming a USD 400 billion production gap. This expansion is projected to create 12 million jobs by 2027 but faces a significant talent gap. Targeted skilling ...